Farmaceutica REMEDIA Balance Sheet

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	55.63	47.66	34.5	18.08	24.22	34.35
Cash & Short-Term Investments	55.63	47.66	34.5	18.08	24.22	34.35
Cash Growth	76.59%	38.14%	90.77%	-25.33%	-29.50%	234.29%
Accounts Receivable	192.7	216.95	184.26	173.7	137.63	130.2
Other Receivables	8.66	5.6	5.29	2.8	3.78	3.3
Receivables	201.35	222.55	189.56	176.5	141.41	133.5
Inventory	60.75	57.21	44.33	46.26	40.6	35.08
Other Current Assets	-	0.04	0.04	0.04	0	0.04
Total Current Assets	317.74	327.45	268.43	240.89	206.23	202.97
Property, Plant & Equipment	44.42	44.99	44.77	41.81	41.43	36.9
Long-Term Investments	0.13	0.01	0.03	0.59	0.3	0.29
Other Intangible Assets	2.28	2.19	1.18	0.8	0.77	0.34
Other Long-Term Assets	2.07	1.49	1.35	2.11	2.35	3.96
Total Assets	366.64	376.12	315.76	286.2	251.07	244.46
Accounts Payable	280.4	290.77	235.2	209.83	175.9	159.02
Accrued Expenses	-	1.37	1.28	1.59	2.15	1.82
Current Portion of Leases	0.08	0.35	0.93	1.2	1.34	0.87
Current Income Taxes Payable	1.91	1.89	0.33	0.16	-	0.12
Other Current Liabilities	3.97	1.51	1.71	1.82	0.97	0.56
Total Current Liabilities	286.36	295.9	239.45	214.6	180.3	162.39
Long-Term Leases	0.53	0.53	1.2	-	-	-
Long-Term Deferred Tax Liabilities	4.55	4.66	4.25	3.18	2.54	2.25
Other Long-Term Liabilities	0	-0	-	-	-0	-0
Total Liabilities	291.45	301.09	244.9	217.77	182.85	164.63
Common Stock	9.86	9.86	9.86	9.86	9.86	10.92
Additional Paid-In Capital	0.76	0.76	0.76	0.76	0.76	0.76
Retained Earnings	25.37	26.11	23.67	20.1	15.79	35.58
Treasury Stock	-1.32	-0.48	-2.26	-0.11	-0.11	-0.11
Comprehensive Income & Other	40.52	38.79	38.84	37.83	41.93	32.68
Total Common Equity	75.19	75.03	70.86	68.43	68.22	79.83
Shareholders' Equity	75.19	75.03	70.86	68.43	68.22	79.83
Total Liabilities & Equity	366.64	376.12	315.76	286.2	251.07	244.46
Total Debt	0.61	0.88	2.13	1.2	1.34	0.87
Net Cash (Debt)	55.02	46.77	32.37	16.88	22.88	33.48
Net Cash Growth	83.69%	44.52%	91.69%	-26.20%	-31.67%	295.79%
Net Cash Per Share	0.48	0.49	0.34	0.18	0.24	0.32
Filing Date Shares Outstanding	95.56	94.66	92.32	95.18	95.18	105.79
Total Common Shares Outstanding	95.56	94.66	92.32	95.18	95.18	105.79
Working Capital	31.37	31.56	28.98	26.3	25.93	40.58
Book Value Per Share	0.79	0.79	0.77	0.72	0.72	0.75
Tangible Book Value	72.91	72.84	69.68	67.64	67.46	79.49
Tangible Book Value Per Share	0.76	0.77	0.75	0.71	0.71	0.75
Land	-	6.03	5.85	5.53	5.41	5.34
Buildings	-	18.97	19.24	16.08	14.42	21.33
Machinery	-	6.9	6.77	8.83	6.39	5.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.